Method of treating cancer with a benzimidazole and a chemotherapeutic agent
AssigneeThe Procter & Gamble Company
InventorJames Berger Camden
Life of this patent
Estimating the term…
Abstract
A method for inhibiting the growth of tumors and cancers in mammals comprising administering a chemotherapeutic agent to significantly reduce the tumor in mass and then administering a benzimidazole derivative. Potentiators can also be included in the benzimidazole composition.
Claims23
A method of treating cancer susceptible to treatment in a warm blooded mammal comprising:
- administering to the mammal a safe and effective amount of a cyclophosphamide to reduce the cancer significantly;
- and
- administering to the mammal a pharmaceutical composition comprising an enhanced safe and effective amount of a benzimidazole of the formula:
- wherein:
- X is hydrogen, halogen, alkyl of less than 7 carbon atoms, or alkoxy of less than 7 carbon atoms;
- n is a positive integer of less than 4;
- Y is hydrogen, chloro, nitro, methyl, or ethyl;
- R is hydrogen, an alkyl group of from 1 to 8 carbon atoms, or CONHR3 wherein R3 is alkyl of less than 7 carbons;
- and
- R2 is 4-thiazolyl or NHCOOR1 wherein R1 is an aliphatic hydrocarbon of less than 7 carbon atoms.
A method of treating cancer susceptible to treatment in a warm blooded mammal comprising administering a safe and effective amount of cyclophosphamide to reduce the cancer significantly and then administering a pharmaceutical composition comprising an enhanced a safe and effective amount of 2-(methoxy-carbonylamino)benzimidazole.
A method of treating cancer susceptible to treatment in a warm blooded mammal comprising the step of:
- administering to the mammal an enhanced effective amount of 2-(methoxycarbonylamino)-benzimidazole and an effective amount of cyclophosphamide.
Dependencies are inferred from the claim text.